Table 2.
Full night attended polysomnographic data at pre and post-treatment
| Subject and treatment | Condition | TST (min) | SE (%) | Stage N3 (%) | REM (%) | AHI | BMI (kg/m2) | Baseline Sats (%) | Nadir O2 Sats (%) |
|---|---|---|---|---|---|---|---|---|---|
| 5 MMA |
pre | 341 | 78 | 9.7 | 24.6 | 26.3 | 23.0 | 100 | 92 |
| post | 374 | 79.5 | 16.4 | 16.3 | 4.3 | 22.1 | 100 | 91 | |
| 6 MMA |
pre | 370 | 89 | 0.4 | 18.5 | 39.4 | 29.4 | 93 | 83 |
| post | 280 | 89 | 4.6 | 29.1 | 10.5 | 28.1 | 92 | 89 | |
| 7* PAP@9cmH2O |
pre | 245 | 52.3 | 36.7 | 3.7 | 53.0 | 31.7 | 100 | 74 |
| post | 354 | 90.3 | 6.6 | 21.2 | 1.8 | 31.7 | 100 | 93 | |
| 8* PAP@8cmH2O |
pre | 440 | 86.3 | 0.0 | 17 | 28.7 | 24.4 | 100 | 92 |
| post | 432 | 88.8 | 0.6 | 2.7 | 11.4 | 24.4 | 100 | 92 |
TST - Total sleep time (minutes)
SE (%) - Sleep Efficiency
N3 - Delta sleep
REM - Rapid eye movement sleep
AHI - apnea hypopnea index
BMI - body mass index (kg/m2)
Sats - oxyhemoglobin saturation;
MMA - maxillary-mandibular advancement
PAP - positive airway pressure.
*
Each CPAP patient was tolerant and maintained the original titration listed (@ cm H2O).